Position: Chief Physician, Oncology Ward 5
Academic position:
• Deputy Director, Guangdong Cancer Prevention and Control Center
• Director, Imaging and Interventional Center, Guangdong Provincial People's Hospital
• Lifetime Professor, Guangdong Provincial People's Hospital
• Adjunct Professor, Sun Yat-sen University
• Recipient of the State Council Special Allowance for Expert Contributions
• Member, Consultation Expert Group, Central Healthcare Office
• Vice Chairman, Interventional Radiology Society, Chinese Medical Association
• Vice Chairperson, Interventional Oncology Diagnosis and Treatment Professional Committee, China Anti-Cancer Association
• Head, Interventional Radiology Group, Guangdong Province
• Editorial Board Member, *Chinese Journal of Radiology*
• Honorary Chairperson, Oncology Branch of the Baiyun District Medical Association
• Former founding Chairperson of the Guangdong Interventional Radiology Society
• Council Member, China Anti-Cancer Association
• Council Member, Chinese Society of Medical Imaging Technology
Areas of Expertise
Professor Luo Pengfei is a pioneer of interventional oncology in my country and the creator of the "Luo Pengfei Protocol for Tumor Diagnosis and Treatment," a method that has been granted an international patent in the Benelux region (Patent No.: LU501835).He graduated from the Department of Medicine at Sun Yat-sen University in 1970 and obtained his Master’s degree in Radiology from Kunming Medical University in 1982. He completed a one-year advanced training program in interventional therapy at Kobe University School of Medicine in Japan and has frequently participated in the Radiological Society of North America (RSNA) annual meetings and Asia-Pacific conferences on cardiovascular and interventional radiology.With over 40 years of experience in interventional oncology research, he possesses extensive expertise in treating solid tumors such as liver cancer, lung cancer, pancreatic cancer, cholangiocarcinoma, head and neck cancer, bone metastases, and liver metastases from colorectal cancer.Since the 1980s, he has conducted in-depth research on more than 20,000 cases of intermediate-to-advanced stage liver cancer and helped formulate the standard treatment protocol combining transcatheter arterial chemoembolization (TACE), ablation, and targeted drug therapy.He received the State Council Special Allowance for outstanding contributions in 1992, the Outstanding Contribution Award from the Chinese Society of Interventional Radiology (9th Congress) in 2010, and was honored as a "Meritorious Figure in Chinese Interventional Radiology" in 2017. He has served as editor-in-chief for professional texts such as *Interventional Oncology: Diagnosis and Treatment* and *Clinical Interventional Therapy*, published over 40 papers in core domestic and international journals, and mentored more than 200 doctoral students, master's students, and visiting scholars.He has achieved remarkable clinical outcomes in the treatment of severe, intermediate-to-advanced stage malignant tumors.
